Supply of Essential Medicines for RAPS Hospital

This tender, identified by Bid Number GEM/2026/B/7988609, is being issued by the Nuclear Power Corporation of India Limited, an organization under the Department of Atomic Energy. The procurement is being managed by the Contracts & Material Management department located at RAPS Hospital, PO-Bhabha Nagar, Rawatbhata, Via-Kota, Rajasthan, approximately 50 Kms from Kota. The tender concerns the supply of "DROP DICYCLOMINE and other medicines," with detailed specifications for each item provided in the attached documents. The Bill of Quantities (BOQ) outlines a total quantity of 22,734 units across various pharmaceutical preparations, including but not limited to Dicyclomine syrup and drops, Mebeverine tablets, Polyethylene Glycol sachets, Mesalazine suppositories, Metronidazole syrup, Ofloxacin syrup, Colistin Sulphate syrup, Racecadotril syrup, Lactobacillus capsules and drops, Streptococcus Fecalis capsules, Nifedipine capsules, Bisoprolol tablets (listed twice), Olmesartan tablets (listed twice), Cilostazol tablets, Metolazone tablets, Furosemide tablets, Mephentermine injection, Spironolactone tablets, and Torasemide tablets. Bids are invited from eligible suppliers for the provision of these essential medicines. The bidding period commences on October 16, 2026, at 2:59 PM and concludes on November 6, 2026, at 4:00 PM. The tender is dated October 16, 2026.